Close
Co-Founder & CEO
Kevin Honaker
Kevin is a skilled STEM commercialization leader with more than eight years’ experience in the healthcare space. Prior to joining BiomeSense, Kevin provided strategic and operational leadership as the Director of Operations for a seed-stage pharmacogenomics spinoff from the University of Chicago.
Kevin is a skilled STEM commercialization leader with more than eight years’ experience in the healthcare space. Prior to joining BiomeSense, Kevin provided strategic and operational leadership as the Director of Operations for a seed-stage pharmacogenomics spinoff from the University of Chicago.
Close
Co-founder
Dr. Jack Gilbert
Jack is a global leader in microbiome research,
co-founding both the Earth Microbiome Project and American Gut Project. He has authored more than 300 peer-reviewed publications and book chapters on ecosystem ecology and is the founding editor-in-chief of mSystems, a journal of the American Society of Microbiology.
Dylan is an experienced biomedical engineer
with over 7 years’ experience in product development encompassing a variety of disciplines, including microfluidics, medical devices, and the microbiome. Prior to joining BiomeSense, he helped support and launch Augmenix’s flagship implantable hydrogel product that saw them acquired by Boston Scientific
in 2018.
Close
CTO
Dylan Nichols
Dylan is an experienced biomedical engineer
with over 7 years’ experience in product development encompassing a variety of disciplines, including microfluidics, medical devices, and the microbiome. Prior to joining BiomeSense, he helped support and launch Augmenix’s flagship implantable hydrogel product that saw them acquired by Boston Scientific
in 2018.
Dylan is an experienced biomedical engineer
with over 7 years’ experience in product development encompassing a variety of disciplines, including microfluidics, medical devices, and the microbiome. Prior to joining BiomeSense, he helped support and launch Augmenix’s flagship implantable hydrogel product that saw them acquired by Boston Scientific
in 2018.
Close
Bioinformatics lead
Yoshiki Vázquez-Baeza
Yoshiki Vázquez-Baeza leads the computational biology and data engineering work at BiomeSense. In his prior role he acted as the Associate Director of Bioinformatics with the Center for Microbiome Innovation at UC San Diego. Yoshiki has a breadth of experience developing open source statistical analysis and visualization tools for microbiome research. Throughout his career he's authored a number of high impact papers on the human microbiome spanning inflammatory bowel diseases, time-series analysis, fecal transplants, cystic fibrosis, population-scale profiling, and microbiome analysis.

Yoshiki has over 10 years of experience in biomedical engineering, computer science and microbiome research, holds a BS in Biomedical Engineering from Universidad Iberoamericana, an MS in Computer Science (Human Computer Interaction) and PhD in Computer Science from UC San Diego.
Dylan is an experienced biomedical engineer
with over 7 years’ experience in product development encompassing a variety of disciplines, including microfluidics, medical devices, and the microbiome. Prior to joining BiomeSense, he helped support and launch Augmenix’s flagship implantable hydrogel product that saw them acquired by Boston Scientific
in 2018.
Close
Mechatronics Engineer
Nikhil Boddu
Nikhil Boddu is the Mechatronics engineer at BiomeSense, providing expertise in electrical control system engineering. At BiomeSense, Nikhil uses his skills to provide support for the mechanical design and help develop required automation needs for the system. He holds a Bachelor of Applied Science in Mechatronics Engineering from the University of Waterloo.
Dylan is an experienced biomedical engineer
with over 7 years’ experience in product development encompassing a variety of disciplines, including microfluidics, medical devices, and the microbiome. Prior to joining BiomeSense, he helped support and launch Augmenix’s flagship implantable hydrogel product that saw them acquired by Boston Scientific
in 2018.
Close
Research Associate
Madison Tuffield
Madison Tuffield is a Research Associate at BiomeSense, developing and validating experimental protocols to support development of the company’s technology. Her previous research experience includes generating and analyzing sequence data to create updated phylogenies of under-researched organisms. She holds a bachelor’s degree in Biology from Macalester College.
Dylan is an experienced biomedical engineer
with over 7 years’ experience in product development encompassing a variety of disciplines, including microfluidics, medical devices, and the microbiome. Prior to joining BiomeSense, he helped support and launch Augmenix’s flagship implantable hydrogel product that saw them acquired by Boston Scientific
in 2018.
Close
Biomedical Engineering Intern
Chandrika Haldar
Chandrika Haldar is a Biomedical Engineering Intern at BiomeSense. She is currently pursuing a Bachelor’s in Biomedical Engineering and Master’s in Biomedical Imaging & Signals from Illinois Institute of Technology. Her previous research experience includes contributions to molecular imaging research for optimizing kinetic models of breast cancer tissue and work on Alzheimer’s disease research to investigate amyloid beta and tau proteins in two genomic mices.
Dylan is an experienced biomedical engineer
with over 7 years’ experience in product development encompassing a variety of disciplines, including microfluidics, medical devices, and the microbiome. Prior to joining BiomeSense, he helped support and launch Augmenix’s flagship implantable hydrogel product that saw them acquired by Boston Scientific
in 2018.
Close
ROLE IN THE TEAM
Full Name
Dylan is an experienced biomedical engineer
with over 7 years’ experience in product development encompassing a variety of disciplines, including microfluidics, medical devices, and the microbiome. Prior to joining BiomeSense, he helped support and launch Augmenix’s flagship implantable hydrogel product that saw them acquired by Boston Scientific
in 2018.
Dylan is an experienced biomedical engineer
with over 7 years’ experience in product development encompassing a variety of disciplines, including microfluidics, medical devices, and the microbiome. Prior to joining BiomeSense, he helped support and launch Augmenix’s flagship implantable hydrogel product that saw them acquired by Boston Scientific
in 2018.
Close
ROLE IN THE TEAM
Full Name
Dylan is an experienced biomedical engineer
with over 7 years’ experience in product development encompassing a variety of disciplines, including microfluidics, medical devices, and the microbiome. Prior to joining BiomeSense, he helped support and launch Augmenix’s flagship implantable hydrogel product that saw them acquired by Boston Scientific
in 2018.
Dylan is an experienced biomedical engineer
with over 7 years’ experience in product development encompassing a variety of disciplines, including microfluidics, medical devices, and the microbiome. Prior to joining BiomeSense, he helped support and launch Augmenix’s flagship implantable hydrogel product that saw them acquired by Boston Scientific
in 2018.
Close
Scientific Advisor
Dr. Rob Knight
Rob Knight, Ph.D., is a recognized global leader in microbiome research and a dynamic force behind several significant research initiatives. The Knight lab has produced many of the software tools and laboratory techniques that enabled high-throughput microbiome science. This includes the QIIME pipeline, an open-source bioinformatics and data analysis program that has been used by thousands of microbiome studies.

Rob, along with BiomeSense co-founder Jack Gilbert, also helped co-found the American Gut Project, one of the world’s largest crowdfunded and crowdsourced scientific research projects exploring links between the human gut and diet, health, lifestyle, exercise, and more.

Beyond these projects, Rob has authored or co-authored numerous articles, given a TED Talk viewed by almost 2 million people, and published multiple books to translate the science of the microbiome to a broad audience. Last fall, he received the NIH’s prestigious Pioneer Award to support his research into developing new approaches to enhance healthy microbiomes.
Jack is a global leader in microbiome research,
co-founding both the Earth Microbiome Project and American Gut Project. He has authored more than 300 peer-reviewed publications and book chapters on ecosystem ecology and is the founding editor-in-chief of mSystems, a journal of the American Society of Microbiology.
Close
Scientific Advisor
Dr. Charles Chiu
Charles Chiu, MD, Ph.D., is a pioneer in using metagenomic analysis for diagnostic and clinical research. An infectious disease physician and microbiologist, he leads a translational research laboratory that has successfully identified and characterized emerging viral pathogens. Charles and his lab have also led the way in discovering new approaches to applying bioinformatics and genomic technologies for clinical and public health applications.
‍
Charles currently leads the Precision Diagnosis of Acute Infectious Diseases study. Its goal is to make metagenomic next-generation sequencing for pathogen detection clinically available for the first time. Charles has been interviewed by several media outlets regarding the coronavirus, including a recent article for Time magazine.
Charles currently leads the Precision Diagnosis of Acute Infectious Diseases study. Its goal is to make metagenomic next-generation sequencing for pathogen detection clinically available for the first time. Charles has been interviewed by several media outlets regarding the coronavirus, including a recent article for Time magazine.
Charles currently leads the Precision Diagnosis of Acute Infectious Diseases study. Its goal is to make metagenomic next-generation sequencing for pathogen detection clinically available for the first time. Charles has been interviewed by several media outlets regarding the coronavirus, including a recent article for Time magazine.
Close
Scientific Advisor & CoFounder
Dr. Savas Tay
Savas Tay is a bioengineer and systems biologist. He has been a pioneer in developing single cell analysis methods and using them to study inflammatory signaling pathways. Dr. Tay has developed several microfluidic and optical technologies for high throughput analysis of biological systems, and authored over 65 peer-reviewed publications.
Rob, along with BiomeSense co-founder Jack Gilbert, also helped co-found the American Gut Project, one of the world’s largest crowdfunded and crowdsourced scientific research projects exploring links between the human gut and diet, health, lifestyle, exercise, and more.
Beyond these projects, Rob has authored or co-authored numerous articles, given a TED Talk viewed by almost 2 million people, and published multiple books to translate the science of the microbiome to a broad audience. Last fall, he received the NIH’s prestigious Pioneer Award to support his research into developing new approaches to enhance healthy microbiomes.
Beyond these projects, Rob has authored or co-authored numerous articles, given a TED Talk viewed by almost 2 million people, and published multiple books to translate the science of the microbiome to a broad audience. Last fall, he received the NIH’s prestigious Pioneer Award to support his research into developing new approaches to enhance healthy microbiomes.
Close
ROLE IN THE TEAM
Full Name
Rob Knight, Ph.D., is a recognized global leader in microbiome research and a dynamic force behind several significant research initiatives. The Knight lab has produced many of the software tools and laboratory techniques that enabled high-throughput microbiome science. This includes the QIIME pipeline, an open-source bioinformatics and data analysis program that has been used by thousands of microbiome studies.
Rob, along with BiomeSense co-founder Jack Gilbert, also helped co-found the American Gut Project, one of the world’s largest crowdfunded and crowdsourced scientific research projects exploring links between the human gut and diet, health, lifestyle, exercise, and more.
Beyond these projects, Rob has authored or co-authored numerous articles, given a TED Talk viewed by almost 2 million people, and published multiple books to translate the science of the microbiome to a broad audience. Last fall, he received the NIH’s prestigious Pioneer Award to support his research into developing new approaches to enhance healthy microbiomes.
Beyond these projects, Rob has authored or co-authored numerous articles, given a TED Talk viewed by almost 2 million people, and published multiple books to translate the science of the microbiome to a broad audience. Last fall, he received the NIH’s prestigious Pioneer Award to support his research into developing new approaches to enhance healthy microbiomes.
Close
ROLE IN THE TEAM
Full Name
Rob Knight, Ph.D., is a recognized global leader in microbiome research and a dynamic force behind several significant research initiatives. The Knight lab has produced many of the software tools and laboratory techniques that enabled high-throughput microbiome science. This includes the QIIME pipeline, an open-source bioinformatics and data analysis program that has been used by thousands of microbiome studies.
Rob, along with BiomeSense co-founder Jack Gilbert, also helped co-found the American Gut Project, one of the world’s largest crowdfunded and crowdsourced scientific research projects exploring links between the human gut and diet, health, lifestyle, exercise, and more.
Beyond these projects, Rob has authored or co-authored numerous articles, given a TED Talk viewed by almost 2 million people, and published multiple books to translate the science of the microbiome to a broad audience. Last fall, he received the NIH’s prestigious Pioneer Award to support his research into developing new approaches to enhance healthy microbiomes.
Beyond these projects, Rob has authored or co-authored numerous articles, given a TED Talk viewed by almost 2 million people, and published multiple books to translate the science of the microbiome to a broad audience. Last fall, he received the NIH’s prestigious Pioneer Award to support his research into developing new approaches to enhance healthy microbiomes.
Close
ROLE IN THE TEAM
Full Name
Rob Knight, Ph.D., is a recognized global leader in microbiome research and a dynamic force behind several significant research initiatives. The Knight lab has produced many of the software tools and laboratory techniques that enabled high-throughput microbiome science. This includes the QIIME pipeline, an open-source bioinformatics and data analysis program that has been used by thousands of microbiome studies.
Rob, along with BiomeSense co-founder Jack Gilbert, also helped co-found the American Gut Project, one of the world’s largest crowdfunded and crowdsourced scientific research projects exploring links between the human gut and diet, health, lifestyle, exercise, and more.
Beyond these projects, Rob has authored or co-authored numerous articles, given a TED Talk viewed by almost 2 million people, and published multiple books to translate the science of the microbiome to a broad audience. Last fall, he received the NIH’s prestigious Pioneer Award to support his research into developing new approaches to enhance healthy microbiomes.
Beyond these projects, Rob has authored or co-authored numerous articles, given a TED Talk viewed by almost 2 million people, and published multiple books to translate the science of the microbiome to a broad audience. Last fall, he received the NIH’s prestigious Pioneer Award to support his research into developing new approaches to enhance healthy microbiomes.
Close
Home
Technology
Team
Home
Technology
Team
On a mission
to transform microbiome precision medicine
We are committed to improving the ability to observe, understand, and leverage the human microbiome precision medicine, with the goal of improving health around the world.
How are we doing this? By rejecting the idea that the way it's being done today is the way it should be done tomorrow. That the barriers of to microbiome adoption are inevitable. What was once thought impossible, we are making routine, laser-focused on a single goal - unlocking microbiome's potential to transform precision medicine.
BiomeSense Team
Our leadership team is focused on unlocking the vast potential of the human gut microbiome by building unique technologies that will disrupt the industry. This bold, innovative approach has led to an integrated workflow that dramatically reduces the cost of exploring the human microbiome, making it possible for clinical trials of all sizes to include this rich source of data in their studies.  More data leads to more knowledge, which leads to more precise medicine.
Co-Founder & CEO
Kevin Honaker
learn more
CTO
Dylan Nichols
learn more
Co-Founder & CEO
Kevin Honaker
learn more
Co-Founder
Dr. Jack Gilbert
learn more
CTO
Dylan Nichols
learn more
Co-Founder & CEO
Kevin Honaker
learn more
Mechatronics Engineer
Nikhil Boddu
learn more
Research Associate
Madison Tuffield
learn more
Bioinformatics lead
Yoshiki Vázquez-Baeza
learn more
Mechatronics Engineer
Nikhil Boddu
learn more
Research Associate
Madison Tuffield
learn more
Biomedical engineering Intern
Chandrika Haldar
learn more
Co-Founder & CEO
Kevin Honaker
learn more
CTO
Dylan Nichols
learn more
Position
Full Name
learn more
Position
Full Name
learn more
Position
Full Name
learn more
Scientific Advisory Board
Our Scientific Advisory Board includes world-renown leaders in human microbiome discovery and innovation, including the founders of the Earth Microbiome Project, American Gut project, and the QIIME platform for microbiome analysis. These experts are actively involved in every stage of BiomeSense’s integrated solution. Their industry expertise and vision ensure we are meeting the needs of clinical researchers today as well as anticipating the future.
Scientific Advisor
Dr. Rob Knight
learn more
Scientific Advisor
Dr. Charles Chiu
learn more
Scientific Advisor
Dr. Rob Knight
learn more
Scientific Advisor
Dr. Charles Chiu
learn more
Scientific Advisor & Cofounder
Dr. Savas Tay
learn more
Co-Founder
Dr. Jack Gilbert
learn more
Scientific Advisor
Dr. Charles Chiu
learn more
Scientific Advisor
Dr. Rob Knight
learn more
role in the team
Full Name
learn more
Co-Founder
Dr. Jack Gilbert
learn more
Scientific Advisor
Dr. Charles Chiu
learn more
Scientific Advisor
Dr. Rob Knight
learn more
role in the team
Full Name
learn more
role in the team
Full Name
learn more
Co-Founder
Dr. Jack Gilbert
learn more
Scientific Advisor
Dr. Charles Chiu
learn more
Scientific Advisor
Dr. Rob Knight
learn more
role in the team
Full Name
learn more
role in the team
Full Name
learn more
role in the team
Full Name
learn more
Calling for
partners today
Collaborating with the world’s best to discover, develop, and deliver microbiome precision medicine.
join us
(C) Biomesense 2021
Site Map
Home
Technology
Team
Contact us
Twitter
Linked In
Facebook
Legal Info
Privacy Policy